7
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T41065 |
Atrial natriuretic factor (1-28) (human, porcine)
Atrial natriuretic factor (1-28) (human, porcine),Atrial natriuretic peptide (1-28) |
||
Atrial natriuretic factor (1-28) from both human and porcine sources is a powerful suppressor of pro-opiomelanocortin (POMC) mRNA, while it only has a modest inhibition effect on βEP-LI release. | |||
TP2221L |
ANP (1-11), rat acetate
Atrial natriuretic factor (1-11) acetate,ANP (1-11), rat醋酸盐,Atriopeptide (1-11) acetate |
Others | Others |
ANP (1-11), rat acetate (Atrial natriuretic factor (1-11) acetate) 是心房利钠因子之一,是 CRF 刺激的 ACTH 分泌的抑制剂。 | |||
TP1218 |
Atrial natriuretic factor (1-28) (rat) TFA
Atrial Natriuretic Peptide (ANP) (1-28), rat TFA |
||
Atrial Natriuretic Peptide (ANP) (1-28),rat (TFA) is the main circulating forms of Atrial Natriuretic Peptide (ANP) in rats, which strongly inhibit the secretion of Ang II - stimulated endothelin-1. | |||
TP1221 |
Atrial Natriuretic Peptide (ANP) (1-28), rat
Atrial natriuretic factor (1-28) (rat) |
||
Atrial Natriuretic Peptide (1-28), rat is the major circulating form of ANP in rats. | |||
T81407 |
Prepro-Atrial Natriuretic Factor (26-55) (human)
|
||
Prepro-Atrial Natriuretic Factor (26-55) (human) 为促进肾皮质与髓质循环GMP水平上升的多肽,同时也增强肾腺苷酸环化酶的活性。 | |||
T76389 |
Prepro-ANF (56-92), human
|
||
Prepro-ANF (56-92), human,是一种人类心房利钠因子的前体,同时也作为鸟苷酸环化酶的激活剂,有助于提升肾膜和肾单位微粒鸟苷酸环化酶的活性。 | |||
T82933 |
Auriculin A
|
||
Auriculin A是一种合成ANF,它对血液动力学具有显著效应。该化合物可阻断犬的肾血管收缩,并在兔子的后肢灌注压、心率及动脉血压的全身调节中发挥作用。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-04327 |
VEGFB Protein, Human, Recombinant (hFc)
VRF,血管内皮生长因子,vascular endothelial growth factor B,V... |
Human | HEK293 Cells |
Vascular endothelial growth factor-B (VEGF-B) is closely related to VEGF-A, an effector of blood vessel growth during development and disease and a strong candidate for angiogenic therapies. In detail, VEGFB can positively prevent the Ang II-induced rising in the size of cardiomyocyte as well as reduce Ang II-induced mRNA and protein levels of β-MHC (β-myosin heavy chain), BNP (brain natriuretic peptide), and ANP (atrial natriuretic peptide). Moreover, VEGFB can regulate the decline of the Ang I... |